Product Images Frovatriptan Succinate
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 6 images provide visual information about the product associated with Frovatriptan Succinate NDC 68462-694 by Glenmark Pharmaceuticals Inc., Usa, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
CTN2.5mg9s.jpg - CTN2.5mg9s
Frovatriptan Succinate Tablets are prescription-only tablets made by Glenmark Pharmaceuticals Inc., USA, and are a treatment for migraines. Each tablet contains 3.91 mg of frovatriptan succinate equivalent to 2.5 mg of frovatriptan. The usual dosage is stated in the accompanying Prescribing Information. This unit-dose package is not child-resistant, so it should be kept out of reach of children. The tablets should be stored at temperatures between 20°C to 25°C (68°F to 77°F); excursions are permitted to 15°C to 30°C (59°F to 86°F). The product is manufactured in India with the manufacturing license number: 25/9/2010. Contact information is provided for Glenmark Pharmaceuticals Inc., USA, for any questions.*
figure-1 - figure 1
figure-2 - figure 2
This appears to be a graph showing the effectiveness of a medication called Frovatriptan Succinate Tablets at 90% effectiveness. The graph shows different percentages of effectiveness over a period of time measured in hours, starting from the initial dose. There are no indications of what the medication is for or what the other percentages may represent.*
glenmark-logo - glenmark logo
logo.jpg - logo
structure - structure
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.